ASP Isotopes is a pre-commercial stage materials company. Co. has license to use proprietary technology, the Aerodynamic Separation Process (ASP technology), developed and licensed to Co. by Klydon Proprietary Ltd (Klydon), for the production, distribution, marketing and sale of all isotopes. Co. operates through its subsidiaries: ASP Isotopes Guernsey Limited, which is focused on the development and commercialization of isotopes for specialized end markets; Enriched Energy LLC, which is focused on the development and commercialization of uranium for the nuclear energy market; and ASP Isotopes UK Ltd, which is the licensee of the ASP technology under the license agreement with Klydon. We show 5 historical shares outstanding datapoints in our coverage of ASPI's shares outstanding history.
Understanding the changing numbers of ASPI shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like ASPI versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching ASPI by allowing them to research ASPI shares outstanding history
as well as any other stock in our coverage universe. |
Free ASPI Email Alerts:
Video: Shares Outstanding Importance
